Harvard Management as of June 30, 2022
Portfolio Holdings for Harvard Management
Harvard Management holds 45 positions in its portfolio as reported in the June 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Alphabet Cap Stk Cl A (GOOGL) | 30.4 | $263M | 121k | 2179.26 | |
Meta Platforms Cl A (META) | 21.2 | $183M | 1.1M | 161.25 | |
Scientific Games (LNW) | 14.6 | $126M | 2.7M | 46.99 | |
Abcellera Biologics (ABCL) | 5.1 | $44M | 4.1M | 10.65 | |
Eqrx | 2.9 | $25M | 5.3M | 4.69 | |
Purecycle Technologies (PCT) | 2.1 | $19M | 2.5M | 7.42 | |
Grab Holdings Class A Ord (GRAB) | 1.6 | $14M | 5.4M | 2.53 | |
Revolution Medicines (RVMD) | 1.5 | $13M | 670k | 19.49 | |
Recursion Pharmaceuticals In Cl A (RXRX) | 1.4 | $12M | 1.5M | 8.14 | |
NVIDIA Corporation (NVDA) | 1.2 | $10M | 66k | 151.59 | |
Meli Kaszek Pioneer Corp Class A Ord | 1.1 | $9.9M | 1.0M | 9.90 | |
Qorvo (QRVO) | 1.1 | $9.9M | 105k | 94.32 | |
Asml Holding N V N Y Registry Shs (ASML) | 1.1 | $9.6M | 20k | 475.87 | |
Relay Therapeutics (RLAY) | 1.0 | $9.1M | 541k | 16.75 | |
Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 1.0 | $8.8M | 107k | 81.75 | |
Advanced Micro Devices (AMD) | 1.0 | $8.6M | 112k | 76.47 | |
10x Genomics Cl A Com (TXG) | 1.0 | $8.4M | 186k | 45.25 | |
Lam Research Corporation | 0.9 | $8.2M | 19k | 426.17 | |
Applied Materials (AMAT) | 0.9 | $8.0M | 88k | 90.99 | |
Analog Devices (ADI) | 0.9 | $8.0M | 55k | 146.09 | |
Intel Corporation (INTC) | 0.9 | $7.8M | 208k | 37.41 | |
Kinnate Biopharma | 0.7 | $6.3M | 498k | 12.61 | |
Micron Technology (MU) | 0.7 | $5.9M | 108k | 55.28 | |
Pliant Therapeutics (PLRX) | 0.5 | $4.5M | 562k | 8.01 | |
Nurix Therapeutics (NRIX) | 0.5 | $4.0M | 315k | 12.67 | |
Tenaya Therapeutics (TNYA) | 0.4 | $3.8M | 673k | 5.63 | |
Rocket Lab Usa (RKLB) | 0.4 | $3.8M | 1.0M | 3.79 | |
Generation Bio (GBIO) | 0.4 | $3.3M | 510k | 6.56 | |
Tango Therapeutics (TNGX) | 0.4 | $3.2M | 708k | 4.53 | |
Affirm Hldgs Com Cl A (AFRM) | 0.4 | $3.1M | 174k | 18.06 | |
Confluent Class A Com (CFLT) | 0.4 | $3.0M | 130k | 23.24 | |
Sana Biotechnology (SANA) | 0.3 | $3.0M | 469k | 6.43 | |
Surrozen | 0.3 | $2.4M | 827k | 2.94 | |
Fulcrum Therapeutics (FULC) | 0.2 | $2.0M | 411k | 4.90 | |
Praxis Precision Medicines I | 0.2 | $1.9M | 779k | 2.45 | |
Purecycle Technologies *w Exp 03/17/202 (PCTTW) | 0.2 | $1.9M | 714k | 2.65 | |
Decibel Therapeutics | 0.2 | $1.4M | 329k | 4.21 | |
Pardes Biosciences | 0.1 | $1.2M | 400k | 3.07 | |
Xilio Therapeutics (XLO) | 0.1 | $1.2M | 416k | 2.92 | |
Pacific Biosciences of California (PACB) | 0.1 | $1.0M | 229k | 4.42 | |
Vigil Neuroscience (VIGL) | 0.1 | $747k | 290k | 2.58 | |
Dyne Therapeutics (DYN) | 0.1 | $737k | 107k | 6.87 | |
Seres Therapeutics (MCRB) | 0.1 | $452k | 132k | 3.43 | |
Gemini Therapeutics | 0.0 | $423k | 250k | 1.69 | |
Magenta Therapeutics | 0.0 | $399k | 333k | 1.20 |